In other countries, the switch to DNA-contaminated MMR happened in different years, and autism rates rose correspondingly in those years. (see links below) Human DNA-contaminated MMR was introduced in Australia in 1989, and autism shot up in 1990. In Denmark, MMR was introduced in 1987 and autism increased sharply. The same is true for Israel, where MMR was introduced in late 1988 and the autism rate increased sharply in 1990. This phenomena is happening in other countries, as well. Indeed, all reliable statistics studied by Sound Choice Pharmaceutical Institute followed this same trend.
Interesting Result of Wakefield Study
Changepoints Correspond to Fetal Vaccines
There is a very fascinating study in the United Kingdom, Sweden, and Norway: Coverage for MMR dropped for a few years starting in 1998 because parents were alarmed by the Wakefield report. The autism rate dropped correspondingly during the same time period. Sadly, after thimerosal was removed from vaccines in those countries, vaccine coverage has risen and autism has continued to rise. The following links show very interesting graphs of the overlapped, correlating bell-shaped curve of MMR coverage and autism declining and rising again.
United Kingdom: http://soundchoice.org/map/united-kingdom/
Statistics taken from Sound Choice interactive map:
*Changepoint statistic is based on birth year of the child, not time of diagnosis, so the changepoint can potentially be before the introduction of the DNA-contaminated vaccine. (Example: Vaccinating a 1-year-old in 1981 would give an autism statistic for 1980 birth year, with the actual diagnosis made in 1982 or later.) The changepoint can be delayed if clinics and pharmacies have a supply of an older vaccine which they used up before starting on the new vaccine. In the graphs on the link above, the rate of autism was at a lower rate of increase before the changepoint, and a higher rate of increase after the changepoint.
**When Andrew Wakefield’s study was published in the U.K. in 1999, proposing a possible correlation of the MMRII with autism because of mercury-laden Thimerosal, many parents declined getting their child vaccinated w/MMRII for a few years. During this time the rate of autism dropped in proportion to the decrease in children receiving MMRII. Thimerosal was removed from the MMRII in the U.K. in 2000 and parents resumed having their children vaccinated, yet sadly, after 2000 the rate of autism in the U.K. has continued to rise. The version of MMRII administered in the U.S. has never contained Thimerosal.